These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36049557)

  • 1. Mammalian Target of Rapamycin Inhibition in Patients With ST-Segment Elevation Myocardial Infarction.
    Stähli BE; Klingenberg R; Heg D; Branca M; Manka R; Kapos I; Müggler O; Denegri A; Kesterke R; Berger F; Stehli J; Candreva A; von Eckardstein A; Carballo D; Hamm C; Landmesser U; Mach F; Moccetti T; Jung C; Kelm M; Münzel T; Pedrazzini G; Räber L; Windecker S; Templin C; Matter CM; Lüscher TF; Ruschitzka F
    J Am Coll Cardiol; 2022 Nov; 80(19):1802-1814. PubMed ID: 36049557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled-Level EVERolimus in Acute Coronary Syndrome (CLEVER-ACS) - A phase II, randomized, double-blind, multi-center, placebo-controlled trial.
    Klingenberg R; Stähli BE; Heg D; Denegri A; Manka R; Kapos I; von Eckardstein A; Carballo D; Hamm CW; Vietheer J; Rolf A; Landmesser U; Mach F; Moccetti T; Jung C; Kelm M; Münzel T; Pedrazzini G; Räber L; Windecker S; Matter CM; Ruschitzka F; Lüscher TF
    Am Heart J; 2022 May; 247():33-41. PubMed ID: 35092722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial.
    Iglesias JF; Muller O; Heg D; Roffi M; Kurz DJ; Moarof I; Weilenmann D; Kaiser C; Tapponnier M; Stortecky S; Losdat S; Eeckhout E; Valgimigli M; Odutayo A; Zwahlen M; Jüni P; Windecker S; Pilgrim T
    Lancet; 2019 Oct; 394(10205):1243-1253. PubMed ID: 31488372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of ST-elevation myocardial infarction versus non-ST-elevation acute coronary syndrome treated with titanium-nitride-oxide-coated versus everolimus-eluting stents: insights from the BASE-ACS trial.
    Romppanen H; Nammas W; Kervinen K; Mikkelsson J; Pietilä M; Lalmand J; Rivero-Crespo F; Pentikäinen M; Tedjokusumo P; Karjalainen PP
    Minerva Cardioangiol; 2013 Apr; 61(2):201-9. PubMed ID: 23492603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results of the randomized comparison of everolimus-eluting stents and sirolimus-eluting stent in patients with ST elevation myocardial infarction (RACES-MI trial).
    Di Lorenzo E; Sauro R; Capasso M; Lanni F; Lanzillo T; Carbone G; Manganelli F; Palmieri V; Serino V; Pagliuca MR; Rosato G; Suryapranata H; De Luca G
    Int J Cardiol; 2016 Jan; 202():177-82. PubMed ID: 26397405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Trimetazidine Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST Segment Elevation Myocardial Infarction Reduces Myocardial Infarction Size.
    Qian G; A X; Jiang X; Jiang Z; Li T; Dong W; Guo J; Chen Y
    Cardiovasc Drugs Ther; 2023 Jun; 37(3):497-506. PubMed ID: 34767131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: the BVS-EXAMINATION Study (bioresorbable vascular scaffold-a clinical evaluation of everolimus eluting coronary stents in the treatment of patients with ST-segment elevation myocardial infarction).
    Brugaletta S; Gori T; Low AF; Tousek P; Pinar E; Gomez-Lara J; Scalone G; Schulz E; Chan MY; Kocka V; Hurtado J; Gomez-Hospital JA; Münzel T; Lee CH; Cequier A; Valdés M; Widimsky P; Serruys PW; Sabaté M
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt B):189-197. PubMed ID: 25616924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-hospital pulse glucocorticoid therapy in patients with ST-segment elevation myocardial infarction transferred for primary percutaneous coronary intervention: a randomized controlled trial (PULSE-MI).
    Madsen JM; Obling LER; Rytoft L; Folke F; Hassager C; Andersen LB; Vejlstrup N; Bang LE; Engstrøm T; Lønborg JT
    Trials; 2023 Dec; 24(1):808. PubMed ID: 38102687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized comparison of everolimus-eluting stents and sirolimus-eluting stents in patients with ST elevation myocardial infarction: RACES-MI trial.
    Di Lorenzo E; Sauro R; Varricchio A; Capasso M; Lanzillo T; Manganelli F; Carbone G; Lanni F; Pagliuca MR; Stanco G; Rosato G; Suryapranata H; De Luca G
    JACC Cardiovasc Interv; 2014 Aug; 7(8):849-56. PubMed ID: 25147029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of attenuated plaque as detected by intravascular ultrasound on the occurrence of microvascular obstruction after percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
    Shiono Y; Kubo T; Tanaka A; Tanimoto T; Ota S; Ino Y; Aoki H; Ozaki Y; Orii M; Shimamura K; Ishibashi K; Yamano T; Yamaguchi T; Hirata K; Imanishi T; Akasaka T
    JACC Cardiovasc Interv; 2013 Aug; 6(8):847-53. PubMed ID: 23871509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction.
    Broch K; Anstensrud AK; Woxholt S; Sharma K; Tøllefsen IM; Bendz B; Aakhus S; Ueland T; Amundsen BH; Damås JK; Berg ES; Bjørkelund E; Bendz C; Hopp E; Kleveland O; Stensæth KH; Opdahl A; Kløw NE; Seljeflot I; Andersen GØ; Wiseth R; Aukrust P; Gullestad L
    J Am Coll Cardiol; 2021 Apr; 77(15):1845-1855. PubMed ID: 33858620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Use of N-acetylcysteine With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Reduces Myocardial Infarct Size (the NACIAM Trial [N-acetylcysteine in Acute Myocardial Infarction]).
    Pasupathy S; Tavella R; Grover S; Raman B; Procter NEK; Du YT; Mahadavan G; Stafford I; Heresztyn T; Holmes A; Zeitz C; Arstall M; Selvanayagam J; Horowitz JD; Beltrame JF
    Circulation; 2017 Sep; 136(10):894-903. PubMed ID: 28634219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet inhibition to target reperfusion injury trial: Rationale and study design.
    Bulluck H; Chan MHH; Bryant JA; Chai P; Chawla A; Chua TS; Chung YC; Fei G; Ho HH; Ho AFW; Hoe AJ; Imran SS; Lee CH; Lim SH; Liew BW; Yun PLZ; Hock MOE; Paradies V; Roe MT; Teo L; Wong AS; Wong E; Wong PE; Watson T; Chan MY; Tan JW; Hausenloy DJ
    Clin Cardiol; 2019 Jan; 42(1):5-12. PubMed ID: 30421441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials.
    de Waha S; Patel MR; Granger CB; Ohman EM; Maehara A; Eitel I; Ben-Yehuda O; Jenkins P; Thiele H; Stone GW
    Eur Heart J; 2017 Dec; 38(47):3502-3510. PubMed ID: 29020248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Low-Dose Intracoronary Alteplase During Primary Percutaneous Coronary Intervention on Microvascular Obstruction in Patients With Acute Myocardial Infarction: A Randomized Clinical Trial.
    McCartney PJ; Eteiba H; Maznyczka AM; McEntegart M; Greenwood JP; Muir DF; Chowdhary S; Gershlick AH; Appleby C; Cotton JM; Wragg A; Curzen N; Oldroyd KG; Lindsay M; Rocchiccioli JP; Shaukat A; Good R; Watkins S; Robertson K; Malkin C; Martin L; Gillespie L; Ford TJ; Petrie MC; Macfarlane PW; Tait RC; Welsh P; Sattar N; Weir RA; Fox KA; Ford I; McConnachie A; Berry C;
    JAMA; 2019 Jan; 321(1):56-68. PubMed ID: 30620371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale and design of a double-blind, multicenter, randomized, placebo-controlled clinical trial of early administration of intravenous β-blockers in patients with ST-elevation myocardial infarction before primary percutaneous coronary intervention: EARLY β-blocker administration before primary PCI in patients with ST-elevation myocardial infarction trial.
    Roolvink V; Rasoul S; Ottervanger JP; Dambrink JH; Lipsic E; van der Horst IC; de Smet B; Kedhi E; Marcel Gosselink AT; Piek JJ; Sanchez-Brunete V; Ibanez B; Fuster V; Van't Hof AW;
    Am Heart J; 2014 Nov; 168(5):661-6. PubMed ID: 25440793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colchicine for Left Ventricular Infarct Size Reduction in Acute Myocardial Infarction: A Phase II, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Protocol - The COVERT-MI Study.
    Bresson D; Roubille F; Prieur C; Biere L; Ivanes F; Bouleti C; Dubreuil O; Rioufol G; Boutitie F; Sideris G; Elbaz M; Bochaton T; De Bourguignon C; El Jonhy N; Dufay N; Dhelens C; Croisille P; Prunier F; Angoulvant D; Ovize M; Maucort-Boulch D; Mewton N
    Cardiology; 2021; 146(2):151-160. PubMed ID: 33582664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Percutaneous Coronary Intervention on Death and Myocardial Infarction Stratified by Stable and Unstable Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials.
    Chacko L; P Howard J; Rajkumar C; Nowbar AN; Kane C; Mahdi D; Foley M; Shun-Shin M; Cole G; Sen S; Al-Lamee R; Francis DP; Ahmad Y
    Circ Cardiovasc Qual Outcomes; 2020 Feb; 13(2):e006363. PubMed ID: 32063040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracoronary ECG during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction predicts microvascular obstruction and infarct size.
    Wong DT; Leung MC; Das R; Liew GY; Teo KS; Chew DP; Meredith IT; Worthley MI; Worthley SG
    Int J Cardiol; 2013 Apr; 165(1):61-6. PubMed ID: 21875755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration.
    Giustino G; Harari R; Baber U; Sartori S; Stone GW; Leon MB; Windecker S; Serruys PW; Kastrati A; Von Birgelen C; Kimura T; Stefanini GG; Dangas GD; Wijns W; Steg PG; Morice MC; Camenzind E; Weisz G; Smits PC; Sorrentino S; Sharma M; Farhan S; Faggioni M; Kandzari D; Galatius S; Jeger RV; Valgimigli M; Itchhaporia D; Mehta L; Kim HS; Chieffo A; Mehran R
    JAMA Cardiol; 2017 Aug; 2(8):855-862. PubMed ID: 28658478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.